Effects	effects	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
inhibitor	inhibitor	O	O	O	O
of	of	O	O	O	O
angiotensin	angiotensin	CHEMICALS	O	OTHERS	I
converting	converting	O	O	O	O
enzyme	enzyme	O	O	O	O
(	(	O	O	O	O
Captopril	captopril	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
on	on	O	O	O	O
pulmonary	pulmonary	O	O	O	O
and	and	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
insufficiency	insufficiency	O	DISEASE	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
intravascular	intravascular	O	O	OTHERS	I
coagulation	coagulation	O	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
rat	rat	O	O	O	O
.	.	O	O	O	O

Induction	induction	O	O	O	O
of	of	O	O	O	O
intravascular	intravascular	O	O	OTHERS	I
coagulation	coagulation	O	O	OTHERS	I
and	and	O	O	O	O
inhibition	inhibition	O	O	O	O
of	of	O	O	O	O
fibrinolysis	fibrinolysis	O	O	O	O
by	by	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
thrombin	thrombin	O	O	O	O
and	and	O	O	O	O
tranexamic	tranexamic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
AMCA	amca	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
rat	rat	O	O	O	O
gives	gives	O	O	O	O
rise	rise	O	O	O	O
to	to	O	O	O	O
pulmonary	pulmonary	O	O	O	O
and	and	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
insufficiency	insufficiency	O	DISEASE	OTHERS	I
resembling	resembling	O	O	O	O
that	that	O	O	O	O
occurring	occurring	O	O	O	O
after	after	O	O	O	O
trauma	trauma	O	O	OTHERS	I
or	or	O	O	O	O
sepsis	sepsis	O	DISEASE	OTHERS	I
in	in	O	O	O	O
man	man	O	O	O	O
.	.	O	O	O	O

Injection	injection	O	O	O	O
of	of	O	O	O	O
Captopril	captopril	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
1	1	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
an	an	O	O	O	O
inhibitor	inhibitor	O	O	O	O
of	of	O	O	O	O
angiotensin	angiotensin	CHEMICALS	O	OTHERS	I
converting	converting	O	O	O	O
enzyme	enzyme	O	O	O	O
(	(	O	O	O	O
ACE	ace	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
reduced	reduced	O	O	O	O
both	both	O	O	O	O
pulmonary	pulmonary	O	O	O	O
and	and	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
insufficiency	insufficiency	O	DISEASE	OTHERS	I
in	in	O	O	O	O
this	this	O	O	O	O
rat	rat	O	O	O	O
model	model	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
lung	lung	O	O	O	O
weights	weights	O	O	O	O
were	were	O	O	O	O
lower	lower	O	O	O	O
and	and	O	O	O	O
PaO2	pao2	O	O	O	O
was	was	O	O	O	O
improved	improved	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
given	given	O	O	O	O
this	this	O	O	O	O
enzyme-blocking	enzyme-blocking	O	O	O	O
agent	agent	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
contents	contents	O	O	O	O
of	of	O	O	O	O
albumin	albumin	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
lungs	lungs	O	O	O	O
were	were	O	O	O	O
not	not	O	O	O	O
changed	changed	O	O	O	O
,	,	O	O	O	O
indicating	indicating	O	O	O	O
that	that	O	O	O	O
Captopril	captopril	CHEMICALS	O	OTHERS	I
did	did	O	O	O	O
not	not	O	O	O	O
influence	influence	O	O	O	O
the	the	O	O	O	O
extravasation	extravasation	O	O	O	O
of	of	O	O	O	O
protein	protein	O	O	O	O
.	.	O	O	O	O

Renal	renal	O	DISEASE	OTHERS	I
damage	damage	O	DISEASE	OTHERS	I
as	as	O	O	O	O
reflected	reflected	O	O	O	O
by	by	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
serum	serum	O	O	O	O
urea	urea	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
in	in	O	O	O	O
kidney	kidney	O	O	O	O
weight	weight	O	O	O	O
was	was	O	O	O	O
prevented	prevented	O	O	O	O
by	by	O	O	O	O
Captopril	captopril	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
amount	amount	O	O	O	O
of	of	O	O	O	O
fibrin	fibrin	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
kidneys	kidneys	O	O	O	O
was	was	O	O	O	O
also	also	O	O	O	O
considerably	considerably	O	O	O	O
lower	lower	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
animals	animals	O	O	O	O
which	which	O	O	O	O
received	received	O	O	O	O
thrombin	thrombin	O	O	O	O
and	and	O	O	O	O
AMCA	amca	CHEMICALS	O	OTHERS	I
alone	alone	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
suggested	suggested	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
Captopril	captopril	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
the	the	O	O	O	O
lungs	lungs	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
attributable	attributable	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
vasodilatory	vasodilatory	O	O	O	O
effect	effect	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
a	a	O	O	O	O
reduction	reduction	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
circulating	circulating	O	O	O	O
level	level	O	O	O	O
of	of	O	O	O	O
Angiotension	angiotension	O	O	OTHERS	I
II	ii	O	O	OTHERS	I
and	and	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
prostacyclin	prostacyclin	O	O	OTHERS	I
(	(	O	O	O	O
secondary	secondary	O	O	O	O
to	to	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
bradykinin	bradykinin	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

Captopril	captopril	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
,	,	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
mechanism	mechanism	O	O	O	O
,	,	O	O	O	O
reduce	reduce	O	O	O	O
the	the	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
glomerular	glomerular	O	O	O	O
filtration	filtration	O	O	O	O
that	that	O	O	O	O
is	is	O	O	O	O
known	known	O	O	O	O
to	to	O	O	O	O
occur	occur	O	O	O	O
after	after	O	O	O	O
an	an	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
thrombin	thrombin	O	O	O	O
,	,	O	O	O	O
thereby	thereby	O	O	O	O
diminishing	diminishing	O	O	O	O
the	the	O	O	O	O
aggregation	aggregation	O	O	O	O
of	of	O	O	O	O
fibrin	fibrin	O	O	O	O
monomers	monomers	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
glomeruli	glomeruli	O	O	O	O
,	,	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
result	result	O	O	O	O
that	that	O	O	O	O
less	less	O	O	O	O
fibrin	fibrin	O	O	O	O
will	will	O	O	O	O
be	be	O	O	O	O
deposited	deposited	O	O	O	O
and	and	O	O	O	O
thus	thus	O	O	O	O
less	less	O	O	O	O
kidney	kidney	O	O	OTHERS	I
damage	damage	O	O	OTHERS	I
will	will	O	O	O	O
be	be	O	O	O	O
produced	produced	O	O	O	O
.	.	O	O	O	O

